Sodium‐glucose cotransporter 2 inhibitor‐associated diabetic ketoacidosis: Report of two cases with hyperglycemic ketoacidosis in type 1 diabetes
作者： Hadi Harati , Vandhna Sharma , Abbas Motazedi
关键词: Sodium glucose transporter 2 、 Type 1 diabetes 、 Diabetes mellitus 、 Diabetic ketoacidosis 、 Canagliflozin 、 Sodium-Glucose Cotransporter 2 Inhibitor 、 Endocrinology 、 Medicine 、 Internal medicine 、 Ketoacidosis
摘要:
sci-hub.se 参考文章(3)
Jamie C. Diner, Irl B. Hirsch, Anne L. Peters, Elizabeth O. Buschur, John B. Buse, Pejman Cohan, Euglycemic Diabetic Ketoacidosis: A Potential Complication of Treatment With Sodium–Glucose Cotransporter 2 Inhibition Diabetes Care. ,vol. 38, pp. 1687- 1693 ,(2015) , 10.2337/DC15-0843
Ele Ferrannini, Elza Muscelli, Silvia Frascerra, Simona Baldi, Andrea Mari, Tim Heise, Uli C. Broedl, Hans-Juergen Woerle, Metabolic response to sodium-glucose cotransporter 2 inhibition in type 2 diabetic patients Journal of Clinical Investigation. ,vol. 124, pp. 499- 508 ,(2014) , 10.1172/JCI72227
Aurora Merovci, Carolina Solis-Herrera, Giuseppe Daniele, Roy Eldor, Teresa Vanessa Fiorentino, Devjit Tripathy, Juan Xiong, Zandra Perez, Luke Norton, Muhammad A. Abdul-Ghani, Ralph A. DeFronzo, Dapagliflozin improves muscle insulin sensitivity but enhances endogenous glucose production Journal of Clinical Investigation. ,vol. 124, pp. 509- 514 ,(2014) , 10.1172/JCI70704